只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-07-02 2026-07-07 | PTHS Pelthos Therapeutics Inc. | Pauls Matthew Director | 卖出（S） | 94 | US$27.36 | US$2,571.88 | 14,364 | SEC |
| 2026-07-01 2026-07-06 | ADPT Adaptive Biotechnologies Corp | BOBULSKY SUSAN Officer · Chief Commercial Officer, MRD | 卖出（S） | 487 | US$22.00 | US$10,714.00 | 406,288 | SEC |
| 2026-07-01 2026-07-02 | ULS UL Solutions Inc. | Scanlon Jennifer F. Director,Officer · President and CEO | 卖出（S） | 4,800 | US$97.92 | US$470,037.12 | 171,924 | SEC |
| 2026-07-01 2026-07-02 | ULS UL Solutions Inc. | Scanlon Jennifer F. Director,Officer · President and CEO | 卖出（S） | 3,600 | US$99.05 | US$356,576.04 | 168,324 | SEC |
| 2026-07-01 2026-07-02 | ULS UL Solutions Inc. | Scanlon Jennifer F. Director,Officer · President and CEO | 卖出（S） | 1,200 | US$100.34 | US$120,409.44 | 167,124 | SEC |
| 2026-07-01 2026-07-02 | ULS UL Solutions Inc. | Scanlon Jennifer F. Director,Officer · President and CEO | 卖出（S） | 2,600 | US$101.05 | US$262,731.04 | 164,524 | SEC |
| 2026-07-01 2026-07-02 | ULS UL Solutions Inc. | Scanlon Jennifer F. Director,Officer · President and CEO | 卖出（S） | 300 | US$101.74 | US$30,522.99 | 164,224 | SEC |
| 2026-06-25 2026-06-29 | ADPT Adaptive Biotechnologies Corp | BOBULSKY SUSAN Officer · Chief Commercial Officer, MRD | 卖出（S） | 5,000 | US$20.50 | US$102,500.00 | 406,775 | SEC |
| 2026-06-17 2026-06-22 | AAMI Acadian Asset Management Inc. | PAULSON & CO. INC. TenPercentOwner | 卖出（S） | 1,900,000 | US$77.25 | US$1.47亿 | 5,843,282 | SEC |
| 2026-06-15 2026-06-16 | PBLS Parabilis Medicines, Inc. | SEBULSKY ALAN Director | 买入（P） | 4,065 | US$27.10 | US$110,161.50 | 30,000 | SEC |
| 2026-06-15 2026-06-16 | PBLS Parabilis Medicines, Inc. | SEBULSKY ALAN Director | 买入（P） | 5,000 | US$26.00 | US$130,000.00 | 25,935 | SEC |
| 2026-06-12 2026-06-16 | PBLS Parabilis Medicines, Inc. | SEBULSKY ALAN Director | 买入（P） | 8,435 | US$27.67 | US$233,396.45 | 20,935 | SEC |
| 2026-06-11 2026-06-15 | PBLS Parabilis Medicines, Inc. | SEBULSKY ALAN Director | 买入（P） | 12,500 | US$20.00 | US$250,000.00 | 12,500 | SEC |
| 2026-06-11 2026-06-15 | ADPT Adaptive Biotechnologies Corp | BOBULSKY SUSAN Officer · Chief Commercial Officer, MRD | 卖出（S） | 5,000 | US$19.00 | US$95,000.00 | 411,775 | SEC |
| 2026-06-09 2026-06-10 | ULS UL Solutions Inc. | PEPPING KAREN K Officer · Senior VP & CAO | 卖出（S） | 725 | US$97.74 | US$70,861.50 | 8,082 | SEC |
| 2026-06-04 2026-06-08 | ADPT Adaptive Biotechnologies Corp | BOBULSKY SUSAN Officer · Chief Commercial Officer, MRD | 卖出（S） | 11,000 | US$18.00 | US$198,000.00 | 416,775 | SEC |
| 2026-06-03 2026-06-04 | ULS UL Solutions Inc. | Schjotz Gitte Officer · See Remarks | 卖出（S） | 9,865 | US$96.98 | US$956,707.70 | 59,341 | SEC |
| 2026-06-02 2026-06-04 | ULS UL Solutions Inc. | Schjotz Gitte Officer · See Remarks | 卖出（S） | 12,015 | US$99.71 | US$119.8万 | 69,206 | SEC |
| 2026-06-01 2026-06-03 | ULS UL Solutions Inc. | Scanlon Jennifer F. Director,Officer · President and CEO | 卖出（S） | 4,995 | US$100.59 | US$502,447.05 | 176,724 | SEC |
| 2026-06-01 2026-06-03 | ULS UL Solutions Inc. | Scanlon Jennifer F. Director,Officer · President and CEO | 卖出（S） | 7,505 | US$99.60 | US$747,498.00 | 181,719 | SEC |
| 2026-05-28 2026-06-01 | ULS UL Solutions Inc. | Uggetti Alberto Officer · EVP & CCO | 卖出（S） | 2,345 | US$99.89 | US$234,242.05 | 7,962 | SEC |
| 2026-05-21 2026-05-22 | ULS UL Solutions Inc. | Hecker Friedrich Director | 卖出（S） | 4,000 | US$102.04 | US$408,160.00 | 13,180 | SEC |
| 2026-05-14 2026-05-15 | KPTI Karyopharm Therapeutics Inc. | Paulson Richard A. Director,Officer · President and CEO | 卖出（S） | 2,203 | US$9.50 | US$20,928.50 | 269,747 | SEC |
| 2026-05-11 2026-05-15 | PLSE PULSE BIOSCIENCES, INC. | DUGGAN ROBERT W Director,TenPercentOwner | 买入（P） | 660,233 | US$19.69 | US$1300万 | 48,370,047 | SEC |
| 2026-05-11 2026-05-13 | ULS UL Solutions Inc. | Uggetti Alberto Officer · EVP & CCO | 卖出（S） | 6,100 | US$100.00 | US$610,000.00 | 10,307 | SEC |
| 2026-05-11 2026-05-11 | PLSE PULSE BIOSCIENCES, INC. | DUGGAN ROBERT W Director,TenPercentOwner | 买入（P） | 660,233 | US$19.69 | US$1300万 | 48,211,433 | SEC |
| 2026-05-11 2026-05-11 | PLSE PULSE BIOSCIENCES, INC. | LAVIOLETTE PAUL A Director,Officer · Chief Executive Officer | 买入（P） | 15,000 | US$19.69 | US$295,350.00 | 15,000 | SEC |
| 2026-05-11 2026-05-11 | PLSE PULSE BIOSCIENCES, INC. | LAVIOLETTE PAUL A Director,Officer · Chief Executive Officer | 买入（P） | 15,000 | US$19.69 | US$295,350.00 | 15,846 | SEC |
| 2026-05-07 2026-05-11 | ULS UL Solutions Inc. | Schjotz Gitte Officer · See Remarks | 卖出（S） | 8,000 | US$103.96 | US$831,680.00 | 81,221 | SEC |
| 2026-05-04 2026-05-04 | FND Floor & Decor Holdings, Inc. | PAULSEN BRADLEY Director,Officer · Chief Executive Officer | 买入（P） | 5,000 | US$50.25 | US$251,250.00 | 85,010 | SEC |
| 2026-05-01 2026-05-01 | ULS UL Solutions Inc. | Scanlon Jennifer F. Director,Officer · President and CEO | 卖出（S） | 2,968 | US$92.01 | US$273,085.68 | 188,274 | SEC |
| 2026-05-01 2026-05-01 | ULS UL Solutions Inc. | Scanlon Jennifer F. Director,Officer · President and CEO | 卖出（S） | 9,532 | US$91.43 | US$871,510.76 | 191,242 | SEC |
| 2026-04-16 2026-04-20 | THM INTERNATIONAL TOWER HILL MINES LTD | PAULSON & CO. INC. TenPercentOwner | 买入（P） | 4,913,665 | US$2.56 | US$1257.9万 | 104,486,703 | SEC |
| 2026-04-02 2026-04-06 | PTHS Pelthos Therapeutics Inc. | Pauls Matthew Director | 卖出（S） | 371 | US$21.36 | US$7,924.56 | 15,150 | SEC |
| 2026-04-02 2026-04-06 | PTHS Pelthos Therapeutics Inc. | Pauls Matthew Director | 卖出（S） | 415 | US$20.52 | US$8,515.80 | 15,521 | SEC |
| 2026-04-01 2026-04-03 | ULS UL Solutions Inc. | Scanlon Jennifer F. Director,Officer · President and CEO | 卖出（S） | 4,923 | US$84.98 | US$418,356.54 | 208,351 | SEC |
| 2026-04-01 2026-04-03 | ULS UL Solutions Inc. | Scanlon Jennifer F. Director,Officer · President and CEO | 卖出（S） | 7,577 | US$85.84 | US$650,409.68 | 200,774 | SEC |
| 2025-12-08 2026-05-15 | ULS UL Solutions Inc. | Genovesi John A Officer · See Remarks | 买入（P） | 30 | US$77.82 | US$2,334.60 | 31,080 | SEC |
| 2025-12-08 2026-05-05 | ULS UL Solutions Inc. | Hancock Lynn H Officer · See Remarks | 买入（P） | 8 | US$77.82 | US$622.56 | 20,602 | SEC |
| 2025-09-08 2026-05-15 | ULS UL Solutions Inc. | Genovesi John A Officer · See Remarks | 买入（P） | 37 | US$63.59 | US$2,352.83 | 31,050 | SEC |
| 2025-06-09 2026-05-15 | ULS UL Solutions Inc. | Genovesi John A Officer · See Remarks | 买入（P） | 33 | US$70.43 | US$2,324.19 | 31,013 | SEC |
| 2025-03-10 2026-05-15 | ULS UL Solutions Inc. | Genovesi John A Officer · See Remarks | 买入（P） | 45 | US$52.32 | US$2,354.40 | 30,980 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| PULS | 1,209,641.6439 | 0 | 1,789,596.9992 | 67.59% | B, Q, N |
| ULS | 129,941.5582 | 1,997 | 221,350.063 | 58.70% | B, Q, N |
| ULST | 11,741.8935 | 0 | 30,110.0394 | 39.00% | B, Q |